TY - JOUR
T1 - Early metastatic colorectal cancers show increased tissue expression of miR-17/92 cluster members in the invasive tumor front
AU - Jepsen, Rikke Karlin
AU - Novotny, Guy Wayne
AU - Klarskov, Louise Laurberg
AU - Bang-Berthelsen, Claus Heiner
AU - Haakansson, Ida Trondhjem
AU - Hansen, Anker
AU - Christensen, Ib Jarle
AU - Riis, Lene Buhl
AU - Høgdall, Estrid
PY - 2018
Y1 - 2018
N2 - Accurate prediction of regional lymph node metastases (LNM) in endoscopically resected pT1 colorectal cancer (CRC) is crucial in treatment stratification for subsequent radical surgery. Several miRNAs have been linked to CRC invasion and metastasis, including the oncogenic miR-17/92 cluster, and expression levels might have predictive value in the risk assessment of early metastatic progression in CRC. We performed global miRNA microarray using tissue samples from the invasive front of pT1 CRC and investigated associations of the miR-17/92 cluster and presence of LNM. In total, 56 matched pT1 CRCs were thoroughly clinicopathologically characterized, and miRNA microarrays were performed on invasive front tissue samples. Global miRNA intensities were screened using paired t-tests between pT1pN+ and pT1pN0. Associations between miR-17/92 and histopathological features were analyzed using general linear models and tumor cell adjusted expression intensities. miR-17-3p and miR-92a were significantly higher expressed in the invasive front of tumors with LNM compared to those without, corresponding to 1.53-fold higher expression of miR-17-3p (95%CI: 1.04–2.24, P =.030) and 1.28-fold higher expression of miR-92a (95%CI: 1.01–1.68, P =.042). An inverse association between miR-19a and presence of high-grade tumor budding was observed (1.55-fold, 95%CI: 1.13–2.12, P =.008). We provide evidence for associations between early regional LNM and high expression levels of the miR-17/92 cluster members: miR-17-3p and miR-92a, in the invasive front of CRC. Our results support a role for the miR-17/92 cluster in early metastatic progression of CRC and calls for further investigation.
AB - Accurate prediction of regional lymph node metastases (LNM) in endoscopically resected pT1 colorectal cancer (CRC) is crucial in treatment stratification for subsequent radical surgery. Several miRNAs have been linked to CRC invasion and metastasis, including the oncogenic miR-17/92 cluster, and expression levels might have predictive value in the risk assessment of early metastatic progression in CRC. We performed global miRNA microarray using tissue samples from the invasive front of pT1 CRC and investigated associations of the miR-17/92 cluster and presence of LNM. In total, 56 matched pT1 CRCs were thoroughly clinicopathologically characterized, and miRNA microarrays were performed on invasive front tissue samples. Global miRNA intensities were screened using paired t-tests between pT1pN+ and pT1pN0. Associations between miR-17/92 and histopathological features were analyzed using general linear models and tumor cell adjusted expression intensities. miR-17-3p and miR-92a were significantly higher expressed in the invasive front of tumors with LNM compared to those without, corresponding to 1.53-fold higher expression of miR-17-3p (95%CI: 1.04–2.24, P =.030) and 1.28-fold higher expression of miR-92a (95%CI: 1.01–1.68, P =.042). An inverse association between miR-19a and presence of high-grade tumor budding was observed (1.55-fold, 95%CI: 1.13–2.12, P =.008). We provide evidence for associations between early regional LNM and high expression levels of the miR-17/92 cluster members: miR-17-3p and miR-92a, in the invasive front of CRC. Our results support a role for the miR-17/92 cluster in early metastatic progression of CRC and calls for further investigation.
KW - Colorectal cancer
KW - Invasive tumor front
KW - Metastases
KW - Microarray
KW - MicroRNA
KW - MiR-17/92
KW - pT1
U2 - 10.1016/j.humpath.2018.05.027
DO - 10.1016/j.humpath.2018.05.027
M3 - Journal article
C2 - 29902577
AN - SCOPUS:85052877745
SN - 0046-8177
VL - 80
SP - 231
EP - 238
JO - Human Pathology
JF - Human Pathology
ER -